Matura Wins Inaugural Award to Advance Pulmonary Hypertension Science and Care
The PHAB Awards, is a US-based research grant program created to support clinical research in pulmonary hypertension (PH), with a focus on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The recipients will receive a combined total of $1 million in grants over a two-year period, making the PHAB Awards one of the largest industry-funded grant programs focused on PAH and CTEPH in the US.
The award-winning research aims to fill gaps in knowledge about the treatment and management of PH, translate the use of existing therapies for new patient populations, and predict surgical risk benefit. Award recipients were selected by an independent Grants Review Committee. Eligibility, review and category criteria were modeled after the National Institutes of Health system; entries were graded on significance, investigator(s), innovation, approach, and environment.
The eight award recipients were formally announced at a ceremony during the American College of Chest Physicians (CHEST) Annual Meeting in New Orleans on Sunday, October 20, 2019.